1. IDAI. Rekomendasi Terapi Inhalas pada Anak.
2. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009 Feb;39(2):193-202. doi: 10.1111/j.1365-2222.2008.03157.x. PMID: 19187331; PMCID: PMC2730743.
3. Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment. Journal of Allergy and Clinical Immunology. 2017 Feb 1;139(2):438-47.
4. Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest. 2006 Nov 1;130(5):1301-11.
5. Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC pulmonary medicine. 2017 Dec;17(1):74.
6. Bush A. Pathophysiological mechanisms of asthma. Frontiers in pediatrics. 2019;7.
7. Lu Y, Kared H, Tan SW, Becht E, Newell EW, Van Bever HP, Ng TP, Larbi A. Dynamics of helper CD4 T cells during acute and stable allergic asthma. Mucosal immunology. 2018 Nov;11(6):1640-52.
8. Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. European Respiratory Journal. 2006 Jan 1;27(1):172-87.
9. Hossny E, Rosario N, Lee BW, Singh M, El-Ghoneimy D, Soh JY, Le Souef P. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organization Journal. 2016 Dec;9(1):26.
10. Newton R. Anti-inflammatory glucocorticoids: changing concepts. European journal of pharmacology. 2014 Feb 5;724:231-6.
11. Edsbäcker S, Johansson CJ. Airway selectivity: an update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids. Basic & clinical pharmacology & toxicology. 2006 Jun;98(6):523-36.
12. Alangari AA. Corticosteroids in the treatment of acute asthma. Annals of thoracic medicine. 2014 Oct;9(4):187.
13. Direkwattanachai, C., Aksilp, C., Chatchatee, P., Jirapongsananuruk, O., Kamalaporn, H., Kamchaisatian, W., Lochindarat, S., Ngamtrakulpanit, L., Poachanukoon, O., Trakultivakorn, M. and Teeratakulpisarn, J., 2019. Practical considerations of nebulized corticosteroid in children with acute asthmatic exacerbation: a consensus. Asian Pac J Allergy Immunol, 10.
14. Liang TZ, Chao JH. Inhaled Corticosteroids. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020
15. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2019. Available from: www.ginasthma.org
16. Masoli M, Holt S, Weatherall M, Beasley R. Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. European Respiratory Journal. 2004 Apr 1;23(4):552-8.
17. Chen AH, Zeng GQ, Chen RC, Zhan JY, Sun LH, Huang SK, Yang CZ, Zhong N. Effects of nebulized high‐dose budesonide on moderate‐to‐severe acute exacerbation of asthma in children: A randomized, double‐blind, placebo‐controlled study. Respirology. 2013 Nov;18:47-52.
18. Edmonds ML, Milan SJ, Camargo Jr CA, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database of Systematic Reviews. 2012(12).
19. Sharma S, Harish R, Dutt N, Digra KK. To evaluate the efficacy of nebulized budesonide compared to oral prednisolone in the management of moderate exacerbation of acute asthma. Int J Contemp Pediatr. 2017 Jul;4:1278-83.
20. Razi CH, Akelma AZ, Harmanci K, Kocak M, Can YK. The addition of inhaled budesonide to standard therapy shortens the length of stay in hospital for asthmatic preschool children: a randomized, double-blind, placebo-controlled trial. International archives of allergy and immunology. 2015;166(4):297-303.
21. Saito M, Kikuchi Y, Kawarai AL, Hoshina M. High-dose nebulized budesonide is effective for mild asthma exacerbations in children under 3 years of age. European annals of allergy and clinical immunology. 2017 Jan;49(1):22-7.
22. Wilson AM, McFarlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Chest. 1998 Oct 1;114(4):1022-7.
23. Chian CF, Tsai CL, Wu CP, Chiang CH, Su WL, Chen CW, Perng WC. Five-day course of budesonide inhalation suspension is as effective as oral prednisolone in the treatment of mild to severe acute asthma exacerbations in adults. Pulmonary pharmacology & therapeutics. 2011 Apr 1;24(2):256-60.
24. Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. European Respiratory Journal. 2003 Jun 1;21(6):989-93.
25. Heffler E, Madeira LN, Ferrando M, Puggioni F, Racca F, Malvezzi L, Passalacqua G, Canonica GW. Inhaled corticosteroids safety and adverse effects in patients with asthma. The Journal of Allergy and Clinical Immunology: In Practice. 2018 May 1;6(3):776-81.
26. Kelly HW, Nelson HS. Potential adverse effects of the inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 2003 Sep 1;112(3):469-78.
27. Maijers I, Kearns N, Harper J, Weatherall M, Beasley R. Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma. European Respiratory Journal. 2020 Jan 1;55(1).
28. Ye Q, He XO, D’Urzo A. A review on the safety and efficacy of inhaled corticosteroids in the management of asthma. Pulmonary Therapy. 2017 Jun 1;3(1):1-8.